These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17549641)

  • 21. Successful treatment of all-trans retinoic acid resistant and chemotherapy naïve acute promyelocytic patients with arsenic trioxide--two case reports.
    Lin CP; Huang MJ; Chang IY; Lin WY
    Leuk Lymphoma; 2000 Jun; 38(1-2):191-4. PubMed ID: 10811462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.
    Chen Z; Zhao WL; Shen ZX; Li JM; Chen SJ; Zhu J; Lallemand-Breittenbach V; Zhou J; Guillemin MC; Vitoux D; de Thé H
    Curr Top Microbiol Immunol; 2007; 313():129-44. PubMed ID: 17217042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
    Karlsson J; Øra I; Pörn-Ares I; Påhlman S
    Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide in the treatment of haematological malignancies.
    Kwong YL
    Expert Opin Drug Saf; 2004 Nov; 3(6):589-97. PubMed ID: 15500417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia.
    Look AT
    J Natl Cancer Inst; 1998 Jan; 90(2):86-8. PubMed ID: 9450562
    [No Abstract]   [Full Text] [Related]  

  • 27. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C; Vermes I
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction.
    Li J; Zhu H; Hu J; Mi J; Chen S; Chen Z; Wang Z
    Int J Hematol; 2014 Jul; 100(1):38-50. PubMed ID: 24938378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Hirayama Y; Koyama R; Nagai T; Ohta H; Kondo A; Ishikawa K; Ishitani K; Matsunaga T; Sakamaki S; Niitsu Y
    Intern Med; 2001 Nov; 40(11):1136-9. PubMed ID: 11757771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
    Douer D; Tallman MS
    J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide newly joins treatment strategies for acute promyelocytic leukemia.
    Kuriyama K
    Intern Med; 2001 Dec; 40(12):1165. PubMed ID: 11813833
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
    Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
    Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
    Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
    Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide for the treatment of acute promyelocytic leukemia.
    Lam MS; Ignoffo RJ
    Cancer Pract; 2001; 9(3):155-7. PubMed ID: 11879303
    [No Abstract]   [Full Text] [Related]  

  • 35. Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia.
    Au WY; Tam S; Fong BM; Kwong YL
    Blood; 2006 Apr; 107(7):3012-3. PubMed ID: 16554490
    [No Abstract]   [Full Text] [Related]  

  • 36. Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia.
    Asou N
    Intern Med; 2005 Aug; 44(8):775-6. PubMed ID: 16157968
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
    Soignet SL
    Oncologist; 2001; 6 Suppl 2():11-6. PubMed ID: 11331435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide treatment of relapsed acute promyelocytic leukaemia: initial Australian experience.
    Spencer A; Firkin F
    Aust N Z J Med; 1999 Jun; 29(3):385-6. PubMed ID: 10868510
    [No Abstract]   [Full Text] [Related]  

  • 39. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
    Rojewski MT; Körper S; Schrezenmeier H
    Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.
    Calleja EM; Warrell RP
    Curr Oncol Rep; 2000 Nov; 2(6):519-23. PubMed ID: 11122887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.